ESG26 Aug 2026, 04:17 pm
Marksans Pharma Receives ESG Score of 56
AI Summary
Marksans Pharma Ltd has received an ESG Score of "56" from Crisil ESG Ratings & Analytics Ltd, a SEBI Licensed ESG Rating Provider. This voluntary review was based on publicly available data for Fiscal 2026. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The detailed rating can be accessed via the BSE India website.
Key Highlights
- Marksans Pharma received an ESG Score of 56.
- The rating was provided by Crisil ESG Ratings & Analytics Ltd.
- The review was based on public data for Fiscal 2026.
- This is a voluntary ESG rating disclosure.
- The rating is accessible on the BSE India website.
Price Impact
More from MARKSANS